Makenzie Wesner, NP
Pediatrics · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Makenzie Wesner’s office at (408) 389-3538 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$441
Pharmacies billed $441 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 29) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
29 generic and 0 brand-name prescriptions · $441 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Diazepam | 13 | $73 | $6 |
Money from drug and device companies
$133 in 2024
| 2024 | 2 | 2 | None | $133 |
| 2023 | 1 | 1 | None | $27 |
| 2022 | 4 | 5 | None | $244 |
| 2021 | 4 | 10 | None | $202 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ACADIA Pharmaceuticals | Nuplazid | $100 | 1 payment
|
| Corium | Azstarys | $33 | 1 payment
|
See all 2 published payments
| ACADIA Pharmaceuticals | Meals · 2024-08-22 | Nuplazid | $100 |
| Corium | Meals · 2024-01-25 | Azstarys | $33 |
See earlier years (2023, 2022, 2021)
2023: $27
| Iti | Caplyta | $27 | 1 payment
|
2022: $244
| ACADIA Pharmaceuticals | Nuplazid | $174 | 2 payments
|
| Iti | Caplyta | $32 | 1 payment
|
| Supernus Pharmaceuticals | Qelbree | $24 | 1 payment
|
| Tris Pharma | Dyanavel Xr | $15 | 1 payment
|
2021: $202
| Tris Pharma | Dyanavel Xr | $90 | 4 payments
|
| Supernus Pharmaceuticals | Qelbree | $60 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $37 | 2 payments
|
| Adlon Therapeutics L.P. | Adhansia Xr | $15 | 1 payment
|
Professional record
- NPI
- 1760929459
- Licence
- CA 95005475
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0200X (363LP0200X)
- Mailing address
- 2450 Samaritan Dr, San Jose, CA, 95124
- NPI first listed
- 2017-01-19
- NPI last updated
- 2023-02-06
- NPI record certified
- 2023-02-06
This is when the NPI record was last certified, not a medical board exam.